Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · March 13, 2015

The Utility of IBD Biomarkers in Patients With Irritable Bowel Syndrome

The American Journal of Gastroenterology

 

Additional Info

The American Journal of Gastroenterology
A Meta-Analysis of the Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin, and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS
Am. J. Gastroenterol 2015 Mar 01;110(3)444-454, SB Menees, C Powell, J Kurlander, A Goel, WD Chey

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading